Twist Bioscience Corporation (TWST) Misses Q3 EPS by 8c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($0.56), $0.08 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $118.4 million versus the consensus estimate of $114.54 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
• Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
• UBS Downgrades Borouge PLC (BOROUGE:UH) to Neutral